July 3, 2023
Schedule a meeting with BCN Peptides at Chem Outsourcing (New Jersey, 6th-8th September)! Get to know us better!
2023
2022
2021
2020
2019
2018
2016
Next events
Latest news
September 21, 2023
Antonio Parente, awarded with the Trifermed Award for social impact in healthcare
September 7, 2023
Deeply committed to Environmental sustainability
May 2, 2023
BCNpeptides was in Tides convention at San Diego from 7th to 10th of May 2023
April 17, 2023
BCNpeptides was in CPhI Japan at booth 5K-19 from 19th to 21st of March 2023
March 28, 2023
9th Cataloniabio & Healthtech event
March 23, 2023
BCNpeptides was in DCAT Week at New York from 20th to 23rd of March 2023.
February 23, 2023
SARS-COV-2 peptide tools available!
November 22, 2022
BCN Peptides and Vall d’Hebron demonstrate the efficacy of a new drug to prevent metastasis.
March 26, 2021
BCNpeptides put forward a new potential therapy for the treatment of inflammatory bowel disease (Crohn disease and ulcerative colitis).
April 1, 2020
BCNpeptides, a partner of the European Consortium for the use of SOLNATIDE in COVID-19 patients.
September 4, 2019
BCN Peptides R&D on Atopic Dermatitis.
March 12, 2019
CataloniaBio & HealthTech awards prize recognizing Dr. Antonio Parente´s professional career.
December 20, 2018
Nature publication First-in-Human Personalized Therapeutic Vaccine for Brain Cancer.
February 1, 2016
BCN Peptides R&D on lysosomal storage diseases.
February 1, 2016
BCN Peptides iniciates a collaboration with IDP-Pharma.